Mechanisms of

Iddrisu Ibrahim, Joseph Atia Ayariga, Junhuan Xu, Daniel A Abugri, Robertson K Boakai, Olufemi S Ajayi

Abstract read

In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

International journal of molecular sciences · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Iddrisu IbrahimThe Microbiology Program, College of Science, Technology, Engineering, and Mathematics, Alabama State University, Montgomery, AL 36104, USA.ORCID 0000-0002-9058-1616

Joseph Atia AyarigaThe Microbiology Program, College of Science, Technology, Engineering, and Mathematics, Alabama State University, Montgomery, AL 36104, USA.ORCID 0000-0003-4561-8245

Junhuan XuThe Industrial Hemp Program, College of Science, Technology, Engineering, and Mathematics, Alabama State University, Montgomery, AL 36104, USA.

Daniel A AbugriThe Microbiology Program, College of Science, Technology, Engineering, and Mathematics, Alabama State University, Montgomery, AL 36104, USA.

Robertson K BoakaiThe Microbiology Program, College of Science, Technology, Engineering, and Mathematics, Alabama State University, Montgomery, AL 36104, USA.

Olufemi S AjayiThe Industrial Hemp Program, College of Science, Technology, Engineering, and Mathematics, Alabama State University, Montgomery, AL 36104, USA.ORCID 0000-0002-3556-803X

Funding

United States Department of Education Title III-HBGIRES

6 · The paper itself

Abstract

The emergence of multi-drug resistance (MDR) poses a huge risk to public health globally. Yet these recalcitrant pathogens continue to rise in incidence rate with resistance rates significantly outpacing the speed of antibiotic development. This therefore presents related health issues such as untreatable nosocomial infections arising from organ transplants and surgeries, as well as community-acquired infections that are related to people with compromised immunity, e.g., diabetic and HIV patients, etc. There is a global effort to fight MRD pathogens spearheaded by the World Health Organization, thus calling for research into novel antimicrobial agents to fight multiple drug resistance. Previously, our laboratory demonstrated that Cannabidiol (CBD) is an effective antimicrobial against

Indexed as

antimicrobialsblaTEMCannabidiolergosterolsfimAlipopolysaccharideresistanceSalmonella

Identifiers

PMID40142444

DOI10.3390/microorganisms13030551

PMCPMC11946568

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.